The Role of Alternative Epidermal Growth Factor Receptor Trafficking in Driving Cancer Progression
The Epidermal Growth Factor Receptor (EGFR) is associated with a variety of cancers, including brain, lung, cervix, renal and breast. It is part of a family of receptors known as the ErbB receptors (ErbB1/EGFR, ErbB2/HER2, ErbB3/HER3, and ErbB4/HER4), transmembrane proteins found on epithelial cells...
Main Author: | Maisel, Sabrina |
---|---|
Other Authors: | Schroeder, Joyce A. |
Language: | en_US |
Published: |
The University of Arizona.
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/624472 http://arizona.openrepository.com/arizona/handle/10150/624472 |
Similar Items
-
Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration
by: Greenwood, Erin, et al.
Published: (2016) -
Polarity as a Regulator of Metaplasia
by: Greenwood, Erin Barbara, et al.
Published: (2016) -
ZNRF1 Mediates Epidermal Growth Factor Receptor Ubiquitination to Control Receptor Lysosomal Trafficking and Degradation
by: Chia-Hsing Shen, et al.
Published: (2021-04-01) -
Internalization, Intracellular Trafficking, Biodistribution of Monoclonal Antibody 806: A Novel Anti-Epidermal Growth Factor Receptor Antibody
by: Rushika M. Perera, et al.
Published: (2007-12-01) -
Epidermal growth factor-mediated Rab25 pathway regulates integrin β1 trafficking in colon cancer
by: Kyung Sook Hong, et al.
Published: (2018-03-01)